The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2023

Filed:

Jun. 30, 2021
Applicant:

Abbott Rapid Diagnostics International Unlimited Company, Dublin, IE;

Inventors:

Arne Ludvig Faaren, Oslo, NO;

Frank Frantzen, Oslo, NO;

Arne Kristian Nordhei, Oslo, NO;

Erling Sundrehagen, Oslo, NO;

Lars Ørning, Oslo, NO;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/26 (2006.01); C12Q 1/60 (2006.01); C12Q 1/61 (2006.01); G01N 33/92 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/60 (2013.01); C12Q 1/61 (2013.01); G01N 33/92 (2013.01);
Abstract

The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component. The method includes: i) diluting the sample with a reagent mixture; ii) substantially removing blood cells; iii) using a reagent which serves to temporarily prevent reaction of the second component, to generate a blocked second component; iv) causing the selective reaction of a constituent of each analyte to directly or indirectly generate detectable reaction products, where one of the analytes is the first component; v) monitoring the detectable reaction product or products; vi) relating an amount of the detectable product or products and/or a rate of formation of the detectable product or products to the concentration of each analyte, where the concentration of at least the first component is related to a corresponding detectable reaction product by means of estimating an un-measurable (fictive) endpoint. Step iii) may be carried out at any stage up to and including step iv) but before steps v) or vi). The reagent of step iii) may be applied to the sample separately or may be included in a reagent mixture during steps i) or iv). A corresponding kit is also provided.


Find Patent Forward Citations

Loading…